Scipher Medicine Announces $82 Million Financing
March 24, 2021 08:00 ET
|
Scipher Medicine Corporation
-aMoon and Northpond Ventures led the round.-Additional investors include Echo Health Ventures, Khosla Ventures and Alumni Ventures.-Financing will support commercialization of precision medicine...
Worldwide Genomics in Cancer Care Industry to 2026 - Growing Burden of Cancer is Driving Growth
March 24, 2021 05:53 ET
|
Research and Markets
Dublin, March 24, 2021 (GLOBE NEWSWIRE) -- The "Genomics in Cancer Care Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's...
Progenity Provides Corporate Updates and Reports Fourth Quarter and Full-Year 2020 Financial Results
March 18, 2021 16:05 ET
|
Progenity, Inc.
Reports approximately 82,000 tests in the fourth quarter of 2020 Raised $118M gross proceeds in December 2020 from a concurrent secondary equity offering and issuance of convertible notes, and $25M...
Outlook on the Nanomaterials in Personalized Medicine Global Market to 2025 - Key Drivers and Restraints
March 17, 2021 06:13 ET
|
Research and Markets
Dublin, March 17, 2021 (GLOBE NEWSWIRE) -- The "Nanomaterials in Personalized Medicine: Global Markets" report has been added to ResearchAndMarkets.com's offering. The scope of this report...
4D Path, University of Leeds Extend Contract to Collaboratively Validate New Technology to Help Doctors More Accurately Diagnose Breast Cancer
March 16, 2021 10:00 ET
|
4D Path
NEWTON, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- 4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, has extended its existing partnership with the...
Progenity to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
March 12, 2021 07:30 ET
|
Progenity, Inc.
SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
Worldwide Precision Medicine Industry to 2025 - Targeted Gene Therapy Presents Opportunities
March 12, 2021 05:03 ET
|
Research and Markets
Dublin, March 12, 2021 (GLOBE NEWSWIRE) -- The "Global Precision Medicine Market (2020-2025) by Technology, Sequencing Technology, Products, Applications, End-Users, Route of Administration,...
BlossomHill Therapeutics Closes $71M Series A Financing
March 03, 2021 16:01 ET
|
BlossomHill Therapeutics, Inc.
SAN DIEGO, March 03, 2021 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., a biopharmaceutical company focusing on oncology and autoimmune disorders, announced today that the company raised $71...
Philips and Disney join forces to improve the healthcare experience of children
March 03, 2021 09:00 ET
|
Royal Philips
March 3, 2021 Philips partners with European Hospitals to conduct first of its kind clinical research pilot program that aims to help reduce fear and anxiety to improve children’s patient...
Survey cites enhanced patient experience and anxiety reduction as top benefits of Philips Ambient Experience
March 03, 2021 08:00 ET
|
Royal Philips
March 3, 2021 2000th customer installation of Philips Ambient Experience at bdz Bilddiagnostisches Zentrum Münster in Germany91% of surveyed users are likely or extremely likely to recommend...